However, p16-related oncogenic pathways have been suspected and described in laryngeal cancer, but the effects of p16-positive and HPV-related oncogenicity remain unclear in laryngeal cancers [8]. This evidence concerns the gene CDKN2A and laryngeal carcinoma.